$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000088559013000095 Filed on November 01, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$2.064B	$1.542B	$884.1M
YoY Change	124.3%	74.37%	47.21%
Cost Of Revenue	$731.9M	$560.8M	$216.5M
YoY Change	236.04%	159.04%	33.17%
Gross Profit	$1.332B	$980.9M	$667.6M
YoY Change	89.68%	46.92%	52.43%
Gross Profit Margin	64.54%	63.62%	75.51%
Selling, General & Admin	$450.3M	$355.7M	$188.7M
YoY Change	119.98%	88.54%	39.95%
% of Gross Profit	33.81%	36.26%	28.26%
Research & Development	$59.50M	$49.00M	$19.17M
YoY Change	194.55%	155.61%	9.69%
% of Gross Profit	4.47%	5.0%	2.87%
Depreciation & Amortization	$410.5M	$946.0M	$235.4M
YoY Change	30.98%	301.87%	51.97%
% of Gross Profit	30.82%	96.44%	35.26%
Operating Expenses	$297.7M	$404.7M	$207.8M
YoY Change	-50.74%	94.73%	36.48%
Operating Profit	$1.034B	-$891.5M	$29.46M
YoY Change	956.38%	-3125.73%	-73.78%
Interest Expense	-$266.2M	-$241.4M	-$116.5M
YoY Change	67.53%	107.21%	29.16%
% of Operating Profit	-25.74%		-395.4%
Other Income/Expense, Net
YoY Change
Pretax Income	-$78.10M	-$1.141B	-$89.35M
YoY Change	-71.56%	1177.16%	-853.28%
Income Tax	-$203.1M	-$169.2M	-$96.99M
% Of Pretax Income
Net Earnings	$123.8M	-$971.9M	$7.645M
YoY Change	-238.95%	-12812.88%	-95.82%
Net Earnings / Revenue	6.0%	-63.04%	0.86%
Basic Earnings Per Share		-$2.92	$0.03
Diluted Earnings Per Share	$370.1K	-$2.92	$0.02
COMMON SHARES
Basic Shares Outstanding	333.9M shares	333.6M shares	304.1M shares
Diluted Shares Outstanding		333.6M shares	311.7M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$600.0M	$596.0M	$258.0M
YoY Change	-34.82%	131.01%	0.0%
Cash & Equivalents	$600.0M	$596.3M	$257.7M
Short-Term Investments			$0.00
Other Short-Term Assets	$726.0M	$532.0M	$232.0M
YoY Change	74.52%	129.31%	103.51%
Inventory	$883.0M	$1.076B	$418.3M
Prepaid Expenses
Receivables	$1.676B	$1.643B	$805.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.886B	$3.848B	$1.714B
YoY Change	39.91%	124.57%	55.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.234B	$1.222B	$450.3M
YoY Change	166.72%	171.27%	26.5%
Goodwill	$9.752B	$9.742B	$3.800B
YoY Change	89.68%	156.39%
Intangibles	$12.85B	$13.09B	$8.036B
YoY Change	38.02%	62.9%
Long-Term Investments
YoY Change
Other Assets	$195.5M	$242.0M	$97.47M
YoY Change	6.4%	148.23%	-35.88%
Total Long-Term Assets	$24.05B	$24.36B	$12.43B
YoY Change	58.49%	95.91%	15.99%
TOTAL ASSETS
Total Short-Term Assets	$3.886B	$3.848B	$1.714B
Total Long-Term Assets	$24.05B	$24.36B	$12.43B
Total Assets	$27.93B	$28.20B	$14.15B
YoY Change	55.61%	99.38%	19.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$327.0M	$412.9M	$166.7M
YoY Change	43.81%	147.73%	11.87%
Accrued Expenses	$1.800B	$1.889B	$634.7M
YoY Change	78.55%	197.68%	35.62%
Deferred Revenue
YoY Change
Short-Term Debt	$12.10M	$0.00	$0.00
YoY Change	14.71%
Long-Term Debt Due	$204.8M	$361.0M	$207.7M
YoY Change	-57.35%	73.8%	432.53%
Total Short-Term Liabilities	$2.513B	$2.853B	$1.159B
YoY Change	37.84%	146.27%	34.24%
LONG-TERM LIABILITIES
Long-Term Debt	$17.16B	$17.04B	$7.423B
YoY Change	62.91%	129.62%	43.07%
Other Long-Term Liabilities	$160.5M	$164.0M	$123.5M
YoY Change	-2.71%	32.77%	-78.56%
Total Long-Term Liabilities	$17.32B	$17.21B	$7.546B
YoY Change	61.89%	128.04%	30.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.513B	$2.853B	$1.159B
Total Long-Term Liabilities	$17.32B	$17.21B	$7.546B
Total Liabilities	$22.74B	$23.14B	$10.36B
YoY Change	59.75%	123.37%	32.77%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.279B	-$3.402B	-$2.282B
YoY Change	38.28%	49.1%
Common Stock	$8.530B	$8.512B	$6.187B
YoY Change	37.41%	37.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.119B	$4.949B	$3.785B
YoY Change
Total Liabilities & Shareholders Equity	$27.97B	$28.20B	$14.15B
YoY Change	55.82%	99.38%	19.7%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	$123.8M	-$971.9M	$7.645M
YoY Change	-238.95%	-12812.88%	-95.82%
Depreciation, Depletion And Amortization	$410.5M	$946.0M	$235.4M
YoY Change	30.98%	301.87%	51.97%
Cash From Operating Activities	$279.9M	$201.7M	$166.9M
YoY Change	312.22%	20.85%	-3.91%
INVESTING ACTIVITIES
Capital Expenditures	-$95.10M	$24.90M	$57.07M
YoY Change	5.2%	-56.37%	495.46%
Acquisitions		$4.439B	$245.4M
YoY Change		1709.29%	-40.02%
Other Investing Activities	-$49.50M	-$4.439B	-$234.1M
YoY Change	-97.37%	1796.33%	-44.37%
Cash From Investing Activities	-$144.6M	-$4.469B	-$297.4M
YoY Change	-92.67%	1402.72%	-32.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.300M	$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net		$4.781B	$31.06M
YoY Change		15291.62%	180.15%
Cash From Financing Activities	-130.9M	2.318B	-7.900M
YoY Change	-105.11%	-29446.84%	-102.64%
NET CHANGE
Cash From Operating Activities	279.9M	201.7M	166.9M
Cash From Investing Activities	-144.6M	-4.469B	-297.4M
Cash From Financing Activities	-130.9M	2.318B	-7.900M
Net Change In Cash	4.400M	-1.949B	-138.4M
YoY Change	-99.33%	1308.24%	-561.33%
FREE CASH FLOW
Cash From Operating Activities	$279.9M	$201.7M	$166.9M
Capital Expenditures	-$95.10M	$24.90M	$57.07M
Free Cash Flow	$375.0M	$176.8M	$109.8M
YoY Change	136.89%	60.97%	-33.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	412943000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	227384000	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1889460000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1008224000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-160257000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-119396000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	267118000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	251654000	USD
	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-21110000	USD
	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-35918000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52855000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32476000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	48628000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	5842000	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16000000	USD
CY2012Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18547000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32476000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52855000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	70498000	USD
CY2012Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8979000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	14335000	USD
CY2013Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	27572000	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	910248000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1540021000	USD
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	218187000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	631957000	USD
CY2013Q3	us-gaap	Assets Assets	28204384000	USD
CY2012Q4	us-gaap	Assets Assets	17950379000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	2777451000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	3848363000	USD
CY2012Q4	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	90983000	USD
CY2013Q3	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	53457000	USD
CY2013Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	0	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	11577000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	11197000	USD
CY2013Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	0	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-543133000	USD
CY2012Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-113069000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1045224000	USD
CY2013Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-960328000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5602093000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5745192000	USD
CY2012Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1910348000	USD
CY2013Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1805197000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	25977000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	24428000	USD
CY2012Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4605000	USD
CY2013Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	8650000	USD
CY2012Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-5630000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	33511000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-23198000	USD
CY2013Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	34995000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1128942000	USD
	us-gaap	Cost Of Goods Sold Amortization CostOfGoodsSoldAmortization	0	USD
CY2012Q3	us-gaap	Cost Of Goods Sold Amortization CostOfGoodsSoldAmortization	0	USD
CY2013Q3	us-gaap	Cost Of Goods Sold Amortization CostOfGoodsSoldAmortization	0	USD
	us-gaap	Cost Of Goods Sold Amortization CostOfGoodsSoldAmortization	2557000	USD
CY2013Q3	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	14353000	USD
	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	44241000	USD
CY2013Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	125524000	USD
CY2012Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	102559000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	916091000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	596347000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2539390000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	257730000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164111000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395266000	USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	332757906	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	303861272	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	303861272	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	332757906	shares
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	8260010000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	5940652000	USD
	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications and Revision</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has revised the consolidated statement of comprehensive (loss) income for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three-month</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine-month</font><font style="font-family:inherit;font-size:10pt;"> periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2012</font><font style="font-family:inherit;font-size:10pt;"> to correct the foreign currency translation adjustment, which resulted in an offsetting adjustment to Goodwill and Intangible assets, net. </font></div></div>
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	122223000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	79417000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1030768000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-789599000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	682000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	682000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1030086000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	122223000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-788917000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	79417000	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	560855000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	633618000	USD
CY2012Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	216494000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1605255000	USD
	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	118237000	USD
CY2012Q3	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	13758000	USD
CY2012Q3	us-gaap	Costs And Expenses CostsAndExpenses	854676000	USD
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	2433229000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2382563000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4338827000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	195007000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	221934000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	76422000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	60121000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	124500000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	353500000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	64191000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	4403000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2436219000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1248312000	USD
CY2013Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	945956000	USD
CY2012Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	235311000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	672759000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.13
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.92
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.13
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.92
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	1872000	USD
CY2012Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	965000	USD
CY2013Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	5876000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-4735000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M4D
CY2013Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	32179000	USD
CY2012Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	2367000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	5842000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	48628000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	5842000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	48628000	USD
CY2013Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	32179000	USD
CY2012Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	2367000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1997626000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3469849000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1243488000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1177238000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1230973000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1317121000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1365817000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14022262000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10759419000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10552413000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8761793000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3564000	USD
CY2012Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1603000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	18458000	USD
CY2013Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5079000	USD
CY2012Q3	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-356000	USD
CY2013Q3	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	5408000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	21909000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-3358000	USD
CY2013Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-625000	USD
CY2012Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-229000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-625000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-10780000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2024000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	5822000	USD
CY2012Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2013Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2012Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-155173000	USD
CY2013Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-149601000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-56779000	USD
CY2013Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8161000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-29540000	USD
CY2012Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2322000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2455000	USD
CY2013Q3	us-gaap	Goodwill Goodwill	9742003000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	5141366000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4610800000	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	19852000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-30015000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-119585000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-89347000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1141200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1236339000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-92702000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-169225000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-247700000	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-96992000	USD
CY2012Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	84041000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2710000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	44300000	USD
CY2013Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-53858000	USD
CY2013Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-52961000	USD
CY2012Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	182646000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	81041000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	189249000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	61300000	USD
CY2012Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9787000	USD
CY2013Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	46150000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	105058000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9457000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55018000	USD
CY2013Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-49786000	USD
CY2012Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6324000	USD
CY2012Q3	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-628000	USD
CY2013Q3	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	8245000	USD
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	307000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7361000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2013Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16560188000	USD
CY2012Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11306295000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9308669000	USD
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13090339000	USD
CY2013Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	249306000	USD
CY2012Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	116042000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	581414000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	318681000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	406018000	USD
CY2013Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	824269000	USD
CY2013Q3	us-gaap	Inventory Gross InventoryGross	1172430000	USD
CY2012Q4	us-gaap	Inventory Gross InventoryGross	587287000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	531256000	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	1076088000	USD
CY2013Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	237956000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	120885000	USD
CY2013Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	96342000	USD
CY2012Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	56031000	USD
CY2013Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	110205000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	60384000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3299000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1156000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5336000	USD
CY2013Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2686000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	23143194000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	14232981000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17950379000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28204384000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2853082000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1822752000	USD
CY2013Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	159673000	USD
CY2012Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	103658000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	11015625000	USD
CY2013Q3	us-gaap	Long Term Debt LongTermDebt	17404714000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2101000	USD
CY2013Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	360964000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	480182000	USD
CY2013Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	-18300000000	USD
CY2012Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	-11700000000	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17043750000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10535443000	USD
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	2024000	USD
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	5822000	USD
CY2013Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2012Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2013Q3	us-gaap	Minority Interest MinorityInterest	112077000	USD
CY2012Q4	us-gaap	Minority Interest MinorityInterest	0	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a multinational, specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical and over-the-counter (“OTC”) products, primarily in the areas of eye health, dermatology, neurology and branded generics, as well as medical devices. </font><font style="font-family:inherit;font-size:10pt;">Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act (BCBCA). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2013, the Company acquired Bausch & Lomb Holdings Incorporated (“B&L”), pursuant to an Agreement and Plan of Merger, as amended (the “Merger Agreement”) dated May 24, 2013, with B&L surviving as a wholly-owned subsidiary of Valeant Pharmaceuticals International (“Valeant”), a wholly-owned subsidiary of the Company (the “B&L Acquisition”). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 11, 2012</font><font style="font-family:inherit;font-size:10pt;">, the Company completed the acquisition of Medicis Pharmaceutical Corporation (“Medicis”) through a wholly-owned subsidiary pursuant to an Agreement and Plan of Merger, dated as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 2, 2012</font><font style="font-family:inherit;font-size:10pt;">, with Medicis surviving as a wholly-owned subsidiary of the Company (the “Medicis Acquisition”). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information regarding the B&L Acquisition and the Medicis Acquisition, see note 3 titled “BUSINESS COMBINATIONS”.</font></div></div>
CY2013Q3	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-1943043000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	93619000	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-137536000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-319744000	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2318478000	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-7932000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4158640000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	495004000	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-297396000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-5235738000	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4469109000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-991916000	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	201712000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	762089000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	588659000	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	166827000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2013Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1268000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1268000	USD
CY2012Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26883000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-973243000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7645000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-989907000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4264725000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	46336000	USD
CY2012Q3	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2013Q3	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4222142000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	114578000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	106300000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	4000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	3964000	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	113496000	USD
CY2013Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	29464000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	177770000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-891498000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-632979000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	183747000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	241952000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	4000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	5000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-199000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-400000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-40477000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	183063000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	114178000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-41063000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	107531000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	106300000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-41447000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	183058000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-41447000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3584000	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	163979000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	164968000	USD
CY2012Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7867000	USD
CY2013Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4778000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7422000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	15540000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	14698000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	39551000	USD
CY2012Q3	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	37739000	USD
CY2013Q3	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	150000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55629000	USD
CY2012Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	280724000	USD
CY2012Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	22562000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	80489000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	25104000	USD
CY2013Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	46853000	USD
CY2013Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30700000	USD
CY2012Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7376000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	35918000	USD
CY2013Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14387000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	21110000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5190385000	USD
CY2012Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	245367000	USD
CY2013Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4439325000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	972199000	USD
CY2012Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6305000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8865000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	38068000	USD
CY2013Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4852000	USD
CY2012Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57069000	USD
CY2013Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24932000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51735000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	81786000	USD
CY2012Q3	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7200000	USD
CY2013Q3	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2101000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2013Q3	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2101000	USD
CY2012Q3	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2012Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	400000	USD
CY2013Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	300000	USD
CY2012Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	5325000	USD
CY2013Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	230978000	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	257389000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	130279000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2269880000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-1370000	USD
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2013Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7165121000	USD
CY2012Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	122295000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1408705000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7505121000	USD
CY2012Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	17020000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	9412000	USD
CY2013Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	27430000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	76967000	USD
CY2013Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2012Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10717000	USD
CY2013Q3	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4764000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	23406000	USD
CY2012Q3	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8930000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	28530000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7109000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12228000	USD
CY2012Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5209000	USD
CY2013Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2538000	USD
	us-gaap	Profit Loss ProfitLoss	-988639000	USD
CY2012Q3	us-gaap	Profit Loss ProfitLoss	7645000	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-971975000	USD
	us-gaap	Profit Loss ProfitLoss	-26883000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	462724000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1221606000	USD
CY2013Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	1643148000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	913835000	USD
CY2013Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2012Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3975000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	461056000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5385768000	USD
CY2012Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	31063000	USD
CY2013Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4781025000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	37530000	USD
CY2012Q3	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	4820000	USD
CY2013Q3	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	25258000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	26402000	USD
CY2013Q3	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	18839000	USD
CY2012Q3	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	19145000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	57396000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	65386000	USD
CY2012Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	19170000	USD
CY2013Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	49009000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	58887000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	97273000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	128811000	USD
CY2013Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	123981000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	149868000	USD
CY2012Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	145300000	USD
CY2013Q3	us-gaap	Restructuring Charges RestructuringCharges	295890000	USD
CY2012Q3	us-gaap	Restructuring Charges RestructuringCharges	42872000	USD
	us-gaap	Restructuring Charges RestructuringCharges	398540000	USD
	us-gaap	Restructuring Charges RestructuringCharges	135213000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3402294000	USD
CY2012Q3	us-gaap	Revenues Revenues	884140000	USD
	us-gaap	Revenues Revenues	2560333000	USD
CY2013Q3	us-gaap	Royalty Revenue RoyaltyRevenue	16471000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2370976000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	148348000	USD
	us-gaap	Revenues Revenues	3705848000	USD
CY2013Q3	us-gaap	Revenues Revenues	1541731000	USD
CY2012Q3	us-gaap	Royalty Revenue RoyaltyRevenue	12248000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	39651000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3608801000	USD
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1506421000	USD
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	852747000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2346599000	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	188660000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	854909000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	355637000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	551386000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	52855000	USD
CY2012Q3	us-gaap	Share Based Compensation ShareBasedCompensation	18547000	USD
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	16000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	32476000	USD
CY2013Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	14300000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	27058824	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2269320000	USD
CY2013Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2300000000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12224000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3606000	USD
CY2013Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	7706	shares
CY2013Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	225000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	280724000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	55629000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	3717398000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	4949113000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3717398000	USD
CY2013Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5061190000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3929830000	USD
CY2012Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3731704000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	300000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	42500000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	2000000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	145000000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full year.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</font></div></div>
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	311743000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	316462000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	305550000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	333643000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	304075000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	316462000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	305550000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	333643000	shares
	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	49401000	USD
CY2013Q3	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	149400000	USD
CY2012Q3	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	6009000	USD
	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	219159000	USD
CY2012Q3	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	6833000	USD
	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	12936000	USD
CY2013Q3	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	16120000	USD
	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	36690000	USD
CY2013Q3	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	910248000	USD
	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1540021000	USD
	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	629400000	USD
CY2012Q3	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	218187000	USD
CY2013Q3	vrx	Availablefor Sale Debt Securities Gross Unrealized Gain Accumulatedin Investments AvailableforSaleDebtSecuritiesGrossUnrealizedGainAccumulatedinInvestments	0	USD
CY2012Q4	vrx	Availablefor Sale Debt Securities Gross Unrealized Gain Accumulatedin Investments AvailableforSaleDebtSecuritiesGrossUnrealizedGainAccumulatedinInvestments	380000	USD
CY2012Q4	vrx	Availablefor Sale Debt Securities Gross Unrealized Loss Accumulatedin Investments AvailableforSaleDebtSecuritiesGrossUnrealizedLossAccumulatedinInvestments	0	USD
CY2013Q3	vrx	Availablefor Sale Debt Securities Gross Unrealized Loss Accumulatedin Investments AvailableforSaleDebtSecuritiesGrossUnrealizedLossAccumulatedinInvestments	0	USD
	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	67355000	USD
CY2012Q3	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	17257000	USD
CY2013Q3	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	0	USD
	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	143285000	USD
CY2013Q3	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	148700000	USD
	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	216600000	USD
CY2013Q3	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	7200000	USD
	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	19600000	USD
CY2013Q3	vrx	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-2.88
	vrx	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-1.63
CY2012Q3	vrx	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-0.34
	vrx	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-3.13
	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-33511000	USD
	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	23198000	USD
CY2012Q3	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	5630000	USD
CY2013Q3	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-34995000	USD
CY2013Q3	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	255513000	USD
CY2012Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	352523000	USD
CY2013Q3	vrx	Deferred Compensation Arrangementwith Individual Compensation Expense Increase Decrease Reclassificationof Award DeferredCompensationArrangementwithIndividualCompensationExpenseIncreaseDecreaseReclassificationofAward	21300000	USD
	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-127802000	USD
CY2012Q3	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-107093000	USD
	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-286186000	USD
CY2013Q3	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-185611000	USD
	vrx	Loss Contingency Numberof Class Action Cases LossContingencyNumberofClassActionCases	13	cases
CY2012Q3	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	1000	USD
CY2013Q3	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	-197000	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	0	USD
CY2013Q3	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	0	USD
CY2012Q3	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	0	USD
CY2013Q3	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	0	USD
CY2012Q3	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	0	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	3963000	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	1634000	USD
CY2012Q3	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax	0	USD
	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2013Q3	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax	0	USD
	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax	7000	USD
CY2012Q3	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2013Q3	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	0	USD
	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	0	USD
	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	3584000	USD
	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	6219000	USD
CY2012Q3	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	552000	USD
CY2013Q3	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	3347000	USD
	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	1450000	USD
	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	98069000	USD
	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	79844000	USD
CY2013Q3	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	15130000	USD
CY2012Q3	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	18826000	USD
	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	313584000	shares
CY2013Q3	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	340223000	shares
	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	322949000	shares
	vrx	Repurchase Of Equity Component Of Convertible Debt RepurchaseOfEquityComponentOfConvertibleDebt	2862000	USD
CY2013Q2	vrx	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	85.00
	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	62086000	USD
CY2012Q3	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	62086000	USD
CY2013Q3	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	0	USD
	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	0	USD
	vrx	Settlement Of Convertible Notes SettlementOfConvertibleNotes	-43768000	USD
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	333889863	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q3	vrx	Sharebased Compensation Expense Increase Decrease Reclassificationof Award SharebasedCompensationExpenseIncreaseDecreaseReclassificationofAward	5800000	USD
CY2012Q3	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	3652287000	USD
CY2013Q3	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	6091276000	USD
CY2013Q3	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	185500000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
	dei	Entity Registrant Name EntityRegistrantName	Valeant Pharmaceuticals International, Inc.

Files In Submission

Name	View Source	Status
0000885590-13-000095-index-headers.html	Edgar Link	pending
0000885590-13-000095-index.html	Edgar Link	pending
0000885590-13-000095.txt	Edgar Link	pending
0000885590-13-000095-xbrl.zip	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex2-1.htm	Edgar Link	pending
ex2-2.htm	Edgar Link	pending
ex4-10.htm	Edgar Link	pending
ex4-11.htm	Edgar Link	pending
ex4-12.htm	Edgar Link	pending
ex4-13.htm	Edgar Link	pending
ex4-14.htm	Edgar Link	pending
ex4-15.htm	Edgar Link	pending
ex4-16.htm	Edgar Link	pending
ex4-17.htm	Edgar Link	pending
ex4-18.htm	Edgar Link	pending
ex4-19.htm	Edgar Link	pending
ex4-20.htm	Edgar Link	pending
ex4-21.htm	Edgar Link	pending
ex4-22.htm	Edgar Link	pending
ex4-23.htm	Edgar Link	pending
ex4-24.htm	Edgar Link	pending
ex4-25.htm	Edgar Link	pending
ex4-26.htm	Edgar Link	pending
ex4-27.htm	Edgar Link	pending
ex4-28.htm	Edgar Link	pending
ex4-29.htm	Edgar Link	pending
ex4-3.htm	Edgar Link	pending
ex4-30.htm	Edgar Link	pending
ex4-31.htm	Edgar Link	pending
ex4-32.htm	Edgar Link	pending
ex4-33.htm	Edgar Link	pending
ex4-34.htm	Edgar Link	pending
ex4-35.htm	Edgar Link	pending
ex4-36.htm	Edgar Link	pending
ex4-37.htm	Edgar Link	pending
ex4-38.htm	Edgar Link	pending
ex4-39.htm	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
ex4-40.htm	Edgar Link	pending
ex4-41.htm	Edgar Link	pending
ex4-42.htm	Edgar Link	pending
ex4-43.htm	Edgar Link	pending
ex4-44.htm	Edgar Link	pending
ex4-45.htm	Edgar Link	pending
ex4-46.htm	Edgar Link	pending
ex4-47.htm	Edgar Link	pending
ex4-48.htm	Edgar Link	pending
ex4-49.htm	Edgar Link	pending
ex4-5.htm	Edgar Link	pending
ex4-50.htm	Edgar Link	pending
ex4-51.htm	Edgar Link	pending
ex4-6.htm	Edgar Link	pending
ex4-7.htm	Edgar Link	pending
ex4-8.htm	Edgar Link	pending
ex4-9.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
valeantq32013.htm	Edgar Link	pending
vrx-20130930.xml	Edgar Link	completed
vrx-20130930.xsd	Edgar Link	pending
vrx-20130930_cal.xml	Edgar Link	unprocessable
vrx-20130930_def.xml	Edgar Link	unprocessable
vrx-20130930_lab.xml	Edgar Link	unprocessable
vrx-20130930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2013 Q4 Form 10-Q Financial Statement

#000088559013000095 Filed on November 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2013 Q4 Form 10-Q Financial Statement

#000088559013000095 Filed on November 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc